动脉粥样硬化-话题@MedSci

#动脉粥样硬化#

211篇内容 | 11502人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2117629, encodeId=a29d211e62918, content=<a href='/topic/show?id=c17310539174' target=_blank style='color:#2F92EE;'>#清心解瘀方#</a>（QXJYG）是<a href='/topic/show?id=d08f9802eb3' target=_blank style='color:#2F92EE;'>#陈可冀#</a>院士根据“瘀毒理论”的病因和发病机制用以治疗<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>性<a href='/topic/show?id=974e51e2810' target=_blank style='color:#2F92EE;'>#心血管#</a>疾病（ASCVD）的代表性处方，包含含有<a href='/topic/show?id=9c2d1031961f' target=_blank style='color:#2F92EE;'>#黄芪#</a>、<a href='/topic/show?id=5eb12311579' target=_blank style='color:#2F92EE;'>#丹参#</a>、<a href='/topic/show?id=b1e5105392b0' target=_blank style='color:#2F92EE;'>#川芎#</a>、<a href='/topic/show?id=34a41053e98a' target=_blank style='color:#2F92EE;'>#藿香#</a>和<a href='/topic/show?id=f1d810446422' target=_blank style='color:#2F92EE;'>#黄连#</a>。<a href='/topic/show?id=afa5965438d' target=_blank style='color:#2F92EE;'>#铁死亡#</a>, objectTitle=J Ethnopharmacol：清心解瘀颗粒通过调节GPX4/xCT信号通路抑制铁死亡并稳定动脉粥样硬化斑块, objectType=article, longId=748417, objectId=9872e48417b7, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221119/1668829474049_92910.png, objectUrl=/article/show_article.do?id=9872e48417b7, replyNumber=0, likeNumber=256, createdTime=2023-03-05, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9872e48417b7, moduleTitle=J Ethnopharmacol：清心解瘀颗粒通过调节GPX4/xCT信号通路抑制铁死亡并稳定动脉粥样硬化斑块, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9872e48417b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2109400, encodeId=da292109400f0, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习新知识，新技能, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=87, createdTime=2023-01-08, rootId=0, userName=146480bem82暂无昵称, userId=05155126416, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2106313, encodeId=b4db210631349, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习知识, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=85, createdTime=2022-12-16, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2106314, encodeId=9aac210631430, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习知识, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=96, createdTime=2022-12-16, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1241730, encodeId=2aa21241e30b9, content=20mg/d的<a href='/topic/show?id=a1b568e39e5' target=_blank style='color:#2F92EE;'>#瑞舒伐他汀#</a>可显著降低中国成年亚临床<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>患者2年内的<a href='/topic/show?id=c0924e16c0' target=_blank style='color:#2F92EE;'>#CIMT#</a>进展，且耐受性良好。其一，剂量是不是过大？其二，亚临床需要治疗？, objectTitle=Stroke：瑞舒伐他汀减缓颈动脉内膜-中层厚度的进展, objectType=article, longId=737240, objectId=6ca3e37240ca, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220828/1661684254220_1739456.jpg, objectUrl=/article/show_article.do?id=6ca3e37240ca, replyNumber=0, likeNumber=138, createdTime=2022-08-29, rootId=0, userName=循证小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6ca3e37240ca, moduleTitle=Stroke：瑞舒伐他汀减缓颈动脉内膜-中层厚度的进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6ca3e37240ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1232038, encodeId=9a641232038d6, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>坚持学习谢谢分享谢谢分享, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=94, createdTime=2022-07-12, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1219583, encodeId=8bdf121958382, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习新知识, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=87, createdTime=2022-05-14, rootId=0, userName=ms300, userId=e2716443372, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1215621, encodeId=95511215621b8, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>考虑到动脉粥样硬化斑块的稳定性是评价疾病严重程度的最临床相关的特征之一，而且在这项研究中，ABC的组分也在分离出的受到动脉粥样硬化的人类动脉中被确定，因此这些研究结果具有非常重要的转化潜力。论文共同作者、IRCCS研究所血管神经学与转化医学系主任Giuseppe Lembo教授，“这是一个全新的视角，它为新的课程和以前无法预见的治疗策略铺平了道路。一种假设是，通过特定的生物电子设备和许多其他潜在手段来影响到达脾脏的神经，特别是连接腹腔神经节的迷走神经分支。换句话说，通过非药物治疗来对抗动脉粥样硬化。”, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=101, createdTime=2022-04-29, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=1), GetTopicListResponse(id=1210371, encodeId=d8df12103e176, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>打卡学习谢谢分享学习了, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=113, createdTime=2022-04-11, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1209100, encodeId=50fd1209100a0, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>多学习不后悔坚持打卡, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=100, createdTime=2022-04-06, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1208496, encodeId=5c08120849685, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习了, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=98, createdTime=2022-04-04, rootId=0, userName=1212ba38m22暂无昵称, userId=5b9d2233692, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1208494, encodeId=eabd120849455, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习了, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=87, createdTime=2022-04-04, rootId=0, userName=1212ba38m22暂无昵称, userId=5b9d2233692, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1206183, encodeId=98cf120618329, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习了谢谢分享学习了, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=95, createdTime=2022-03-26, rootId=0, userName=联通药师, userId=1cec6421688, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1205964, encodeId=042e1205964d7, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习了谢谢分享学习了, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=92, createdTime=2022-03-25, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1205314, encodeId=e1dd120531428, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>不管明天。做一个努力拼搏自已, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=81, createdTime=2022-03-23, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1204777, encodeId=128d1204e7737, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>坚持学习等待明天更好的自已, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=123, createdTime=2022-03-21, rootId=0, userName=齐广西, userId=3d162090300, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1204458, encodeId=25341204458b5, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习增加知识储备, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=134, createdTime=2022-03-20, rootId=0, userName=齐广西, userId=3d162090300, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1203395, encodeId=e11c120339598, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=86, createdTime=2022-03-17, rootId=0, userName=ms9000002138466017, userId=1e556504447, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202589, encodeId=493512025895a, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习了学习了谢谢学习了, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=145, createdTime=2022-03-14, rootId=0, userName=移动雪莲, userId=62926421654, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1202251, encodeId=f980120225173, content=<a href='/topic/show?id=98773329350' target=_blank style='color:#2F92EE;'>#动脉粥样硬化#</a>学习了谢谢分享, objectTitle=动脉粥样硬化, objectType=topic, longId=33293, objectId=null, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020121/1606817869803_4754896.jpeg, objectUrl=null, replyNumber=0, likeNumber=118, createdTime=2022-03-13, rootId=0, userName=雪莲药师, userId=3d246474217, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

堵心又堵血管

2020-05-29

循证小兵 (审核中...)

前往app查看评论内容

#清心解瘀方#（QXJYG）是#陈可冀#院士根据“瘀毒理论”的病因和发病机制用以治疗#动脉粥样硬化#性#心血管#疾病（ASCVD）的代表性处方，包含含有#黄芪#、#丹参#、#川芎#、#藿香#和#黄连#。#铁死亡#

J Ethnopharmacol：清心解瘀颗粒通过调节GPX4/xCT信号通路抑制铁死亡并稳定动脉粥样硬化斑块

2023-03-05发表于上海

146480bem82暂无昵称 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习新知识，新技能

2023-01-08

ms300 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习知识

2022-12-16

ms300 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习知识

2022-12-16

循证小兵 (审核中...)

前往app查看评论内容

20mg/d的#瑞舒伐他汀#可显著降低中国成年亚临床#动脉粥样硬化#患者2年内的#CIMT#进展，且耐受性良好。其一，剂量是不是过大？其二，亚临床需要治疗？

Stroke：瑞舒伐他汀减缓颈动脉内膜-中层厚度的进展

2022-08-29

移动雪莲 (审核中...)

前往app查看评论内容

#动脉粥样硬化#坚持学习谢谢分享谢谢分享

2022-07-12

ms300 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习新知识

2022-05-14

yangchou (审核中...)

前往app查看评论内容

全文收起 #动脉粥样硬化#考虑到动脉粥样硬化斑块的稳定性是评价疾病严重程度的最临床相关的特征之一，而且在这项研究中，ABC的组分也在分离出的受到动脉粥样硬化的人类动脉中被确定，因此这些研究结果具有非常重要的转化潜力。论文共同作者、IRCCS研究所血管神经学与转化医学系主任Giuseppe Lembo教授，“这是一个全新的视角，它为新的课程和以前无法预见的治疗策略铺平了道路。一种假设是，通过特定的生物电子设备和许多其他潜在手段来影响到达脾脏的神经，特别是连接腹腔神经节的迷走神经分支。换句话说，通过非药物治疗来对抗动脉粥样硬化。”

2022-04-29

移动雪莲 (审核中...)

前往app查看评论内容

#动脉粥样硬化#打卡学习谢谢分享学习了

2022-04-11

移动雪莲 (审核中...)

前往app查看评论内容

#动脉粥样硬化#多学习不后悔坚持打卡

2022-04-06

1212ba38m22暂无昵称 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习了

2022-04-04

1212ba38m22暂无昵称 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习了

2022-04-04

联通药师 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习了谢谢分享学习了

2022-03-26

移动雪莲 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习了谢谢分享学习了

2022-03-25

雪莲药师 (审核中...)

前往app查看评论内容

#动脉粥样硬化#不管明天。做一个努力拼搏自已

2022-03-23

齐广西 (审核中...)

前往app查看评论内容

#动脉粥样硬化#坚持学习等待明天更好的自已

2022-03-21

齐广西 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习增加知识储备

2022-03-20

ms9000002138466017 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习

2022-03-17

移动雪莲 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习了学习了谢谢学习了

2022-03-14

雪莲药师 (审核中...)

前往app查看评论内容

#动脉粥样硬化#学习了谢谢分享

2022-03-13

科室
- - 订阅+
  - 更多科室
工具
服务